The lipid treatment assessment project (L-TAP): a multicenter survey to evaluate the percentages of dyslipidemic patients receiving lipid-lowering therapy and achieving low-density lipoprotein cholesterol goals.
about
Statins in hypercholesterolaemia: a dose-specific meta-analysis of lipid changes in randomised, double blind trialsEzetimibe for primary hypercholesterolemiaEzetimibe for primary hypercholesterolemiaEzetimibe therapy: mechanism of action and clinical updateThe Myocardial Ischemia Reduction with Acute Cholesterol Lowering trial: MIRACuLous or not, it's time to change current practice.National trends in statin use by coronary heart disease risk categoryComparison of rosuvastatin and atorvastatin for lipid lowering in patients with type 2 diabetes mellitus: results from the URANUS studyCholesterol levels and statin use in patients with coronary heart disease treated in primary care settings.A review of the rationale for additional therapeutic interventions to attain lower LDL-C when statin therapy is not enoughThyroid hormone analogues for the treatment of metabolic disorders: new potential for unmet clinical needs?Cholesterol: the good, the bad, and the ugly - therapeutic targets for the treatment of dyslipidemiaRole of colesevelam in combination lipid-lowering therapyImpact of availability and use of coronary interventions on the prescription of aspirin and lipid lowering treatment after acute coronary syndromesUse of statins and aspirin to reduce risks of cardiovascular diseaseQuality of cardiovascular disease preventive care and physician/practice characteristicsThe impact of a decision aid about heart disease prevention on patients' discussions with their doctor and their plans for prevention: a pilot randomized trialAntiplatelet therapy in populations at high risk of atherothrombosisA new paradigm of cardiovascular risk factor modificationOptimal lipid modification: the rationale for combination therapyTargeted study to evaluate the cardiovascular risk factor status among patients and efficacy of statins in attaining goal lipid levels in a regional hospital in Sultanate of OmanPrevalence of dyslipidemia and lipid goal attainment in statin-treated subjects from 3 data sources: a retrospective analysis.A comparison of Canadian and American guidelines for lipid management using data from the National Cholesterol Education Program Evaluation ProjecT Utilizing Novel E-technology (NEPTUNE) II survey.Application of recent definitions of the metabolic syndrome to survey data from the National Cholesterol Education Program Evaluation Project Utilizing Novel E-Technology (NEPTUNE II).Effectiveness of statins in Medicare-eligible patients and patients < 65 years using clinical practice data.The gender specific frequency of risk factor and CHD diagnoses prior to incident MI: a community study.Does the routine use of global coronary heart disease risk scores translate into clinical benefits or harms? A systematic review of the literature.Implementing the European guidelines for cardiovascular disease prevention in the primary care setting in Cyprus: lessons learned from a health care services studySafety and efficacy of colesevelam HCl in the treatment of elderly patientsPost-prandial lipid levels for assessing target goal achievement in type 2 diabetic patients taking statin.A six-month, multicenter, open-label, noncomparative, prospective, observational study of the efficacy and tolerability of atorvastatin in the primary care setting(estudio del control de las hiperlipidemiasen atención primaria): the cheap studyA randomized clinical trial of secondary prevention among women hospitalized with coronary heart diseasePatterns of serum laboratory monitoring for safety and efficacy in patients on chronic statin therapy.Effectiveness of combined statin plus omega-3 fatty acid therapy for mixed dyslipidemia.Management of patients with suspected angina, but without known myocardial infarction: a cross-sectional survey.The low-density lipoprotein cholesterol-lowering effect of pravastatin and factors associated with achieving targeted low-density lipoprotein levels in an African-American population.Appropriateness of cholesterol management in primary care by sex and level of cardiovascular risk.Prevalence and overlap of different lipid abnormalities in statin-treated patients at high cardiovascular risk in clinical practice in GermanyCholesterol assimilation by Lactobacillus probiotic bacteria: an in vitro investigationPrimary and secondary prevention of heart disease: can we curb the global epidemic?Cholesterol risk management: a systematic examination of the gap from evidence to practice.
P2860
Q21261910-19A9EAA0-731B-4B78-AC91-7FFBCA6C5735Q24187681-9581A230-089E-4C13-ADCE-BB42E56C967AQ24244704-01FDE31F-9D18-411C-BE78-681CB17BF6F9Q24630302-A4A40CE4-6BFC-4F52-AAC3-D62BBD66D192Q24794251-15B7CE0A-AE63-4083-9C28-2F10C416908AQ24810059-26B6530D-94F2-4232-9442-3A8C17B9BD4BQ24814804-0C795788-47E5-4FA8-B5C5-4850668F6C46Q25256963-30077432-35ED-4B05-9397-C95FC2A1D47BQ26824249-DE2CECE4-241C-43F9-ADED-AB3A931AF75DQ26995671-79EDC40B-AFDA-49BE-8609-04DE84ABBA8FQ27013494-CF224EA3-A6BD-4FE1-A565-35FCEBC48705Q27016027-FE32DBD6-62BB-4EC3-A9D9-236D8F091C44Q28193220-32422321-83EF-46A8-8B51-FE826E8DF4F5Q28193248-6A9338C9-603F-44FE-AE53-6BC159060917Q28196755-C7AEAB97-3206-48EC-A862-F6EF6F42CA89Q28200559-DFC4FE30-E1CC-4126-9738-570777903342Q28218702-DA463362-252A-4C27-94B9-F3E5453BE3F6Q28219234-4C1DED96-7639-43C0-B6C2-2C88020A9F30Q28219266-11E771C8-1FCC-421B-B754-B47E353B4035Q28604134-CB3C5B19-F460-4F64-8761-3B437217D62AQ30585937-D5E92DA2-153F-4825-8F50-26D51E69477FQ31035238-AD9C5135-07DA-4945-A516-69B4BF784A74Q31120863-6E04D19B-95AE-4115-BFBA-78E10DB56D4EQ31129888-CFAC4994-F172-4DFB-BF6B-D5B58EC23AFEQ33281123-1C924005-CAF9-49C1-8E25-E35D3B7742CCQ33325717-2A6360BA-3F6C-4FE4-9982-94DC153BB1BDQ33352311-5335EA5B-E043-4C9C-819D-CC7E10C04F9DQ33663484-8CFA54EF-10CF-438C-B71A-962993379E2CQ33680229-5EACAEB6-23E9-42CE-81B3-BC17B889198FQ33738930-93AC7868-4BF6-46A1-9AB3-FFEA19741FB8Q33829406-F6BF6E60-475D-46D4-8D19-E29ACBA1098DQ33949305-502E62E4-8385-49A8-A586-745F635EB35BQ34042886-D6CE6363-E053-4767-B838-1AF205CA1DCEQ34098879-7181480F-6971-4842-B5C0-C2813DC04EB0Q34113763-BC6BFAFB-153F-4C37-AD16-0AC28A189764Q34118658-A9B511C0-C738-4CA2-9B06-A5E67F8ED79EQ34222469-D321DA03-737C-4B14-9DB5-612FA6040EA1Q34250980-08BE85C5-BE1D-41AC-A999-DA4F1426BFF9Q34286619-8ADA62FF-D505-41BE-886A-A5601CB0DDC4Q34303364-91C9A562-BD0B-4814-AB60-6F2DB12D0118
P2860
The lipid treatment assessment project (L-TAP): a multicenter survey to evaluate the percentages of dyslipidemic patients receiving lipid-lowering therapy and achieving low-density lipoprotein cholesterol goals.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
2000年论文
@zh
2000年论文
@zh-cn
name
The lipid treatment assessment ...... lipoprotein cholesterol goals.
@en
type
label
The lipid treatment assessment ...... lipoprotein cholesterol goals.
@en
prefLabel
The lipid treatment assessment ...... lipoprotein cholesterol goals.
@en
P2093
P1476
The lipid treatment assessment ...... lipoprotein cholesterol goals.
@en
P2093
P304
P356
10.1001/ARCHINTE.160.4.459
P407
P577
2000-02-01T00:00:00Z